Company page

Immupharma Plc

Immupharma Plc is a public company listed on the UK market under the ticker IMM, with a market capitalization of approximately £36.3 million. The company focuses on developing innovative therapies for various medical conditions. Immupharma is dedicated to advancing its research and development efforts to bring new treatments to market.